While some say a single-payer system would mean reduced drug prices and expenditures, others argue it could have unintended consequences, particularly for private plan sponsors. Marc-André Gagnon, associate professor at Carleton University’s school of public policy and administration: Canada’s drug coverage is a patchwork without coherence or purpose. Some think more patches can solve the […]
In its 2019 budget on Tuesday, the federal government confirmed it will work with partners to move forward on three foundational elements of national pharmacare. The initial steps are the creation of a new national drug agency and a national formulary, which were both recommended by the advisory council on the implementation of national pharmacare in its interim […]
The advisory council on the implementation of national pharmacare has submitted its interim report to the federal government. The report sets out three initial recommendations for the implementation of national pharmacare: Creating a national drug agency to oversee national pharmacare; Developing a comprehensive, evidence-based list of prescribed drugs — a national formulary — to harmonize coverage […]
While the Canadian Life and Health Insurance Association is in agreement with the general intent of the Ontario government’s proposed changes to the OHIP+ program, it’s strongly encouraging a number of considerations to preserve the revised program as planned and avoid unintended consequences. The proposed amendments would roll back the OHIP+ program, which was introduced […]
The Ontario government is proposing a rollback of OHIP+, which would restrict the free prescription drug coverage program to dependants under age 25 who aren’t covered by private plans. The previous Liberal government implemented the program in January 2018 with an estimated cost of $465 million annually. It covered all OHIP-insured dependants under age 25 […]
As the federal government continues its consultations on a national pharmacare system, many questions are still up in the air. Will the new system follow a single-payer model? And if so, what would be the implications for a private-payer system? As discussions examine the various possibilities, the private industry says pharmacare reform is a complex issue that requires more […]
The introduction of more flexible annuity options for capital accumulation plans and reform to prescription drug coverage are among the recommendations by the Canadian Life and Health Insurance Association for the 2019 federal budget. In a letter to the Ministry of Finance, the CLHIA highlighted the increasing need for Canadian retirees to convert some or all of […]
A majority of Canadians, health-care providers, labour organizations and employers agree a national single-payer system is an idea whose time has come, according to a report by the Broadbent Institute. Canada has attempted to bring in a national pharmacare plan nine times in the last 73 years — in 1945, 1947, 1962, 1964, 1966, 1970, 1997, 2002, and […]
Trends, benefits fraud and drug coverage led the top health and benefits stories in 2018. Benefits Canada rounds up the industry’s favourite health and benefits stories of the year: 1. Seven benefits trends to watch in 2018 2. Ontario unveils new drug, dental coverage for people without workplace benefits 3. TTC fraud update: More than 220 employees fired or have resigned, retired […]
As 2018 draws to a close, and the benefits and pension industry looks ahead, what’s next for the year’s biggest topics? Stephen Frank, president and chief executive officer of the Canadian Life and Health Insurance Association, is expecting a shift from Canadian and global regulators in the way they govern how customers are treated: an […]